Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906214 · ClinicalTrials.gov registry record
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
A clinical trial of Porphyrias, sponsored by University of South Florida.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT03906214 is a study of Porphyrias that has completed, run by University of South Florida. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03906214, a study of Porphyrias, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consortium. The study will be advertised on the Consortium website and through the American Porphyria Foundation's social media network.
Conditions Studied
Interventions
- OTHER Web-based Survey
Study Locations (1)
Florida
- University of South Florida Data Management Coordinating Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2019-09-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03906214
The ClinicalTrials.gov registry entry for NCT03906214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Porphyrias appearing as the primary indexed condition, and to 1 intervention - of which Web-based Survey is the first listed.
NCT03906214 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03906214 about?
NCT03906214 is a clinical study titled "Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria". This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consor...
What is the current status of trial NCT03906214?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-04-03. Estimated completion is 2019-09-13.
What conditions does trial NCT03906214 study?
This clinical trial studies the following conditions: Porphyrias.
What interventions are being tested in trial NCT03906214?
The interventions under investigation include: Web-based Survey (OTHER).
Who is sponsoring clinical trial NCT03906214?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03906214 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.